INS and polycystic ovary syndrome: This study intends to summarize the value and pharmacodynamics of glucagon-like peptide receptor agonists and insulin sensitizers by analyzing the metabolite changes after exenatide combined with metformin or single metformin treatment in PCOS patients who are obese.